ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Immune-and Metabolism-Associated Molecular Classi?cation of Ovarian Cancer

Chen, Zhenyue; Jiang, Weiyi; Li, Zhen; Zong, Yun; Deng, Gaopi*广州中医药大学; 1
Frontiers in Oncology2022-5-12DOI: 10.3389/fonc.2022.877369
5被引4阅读
引用收藏
分享

摘要

Ovarian cancer (OV) is a complex gynecological disease, and its molecular characteristics are not clear. In this study, the molecular characteristics of OV subtypes based on metabolic genes were explored through the comprehensive analysis of genomic data. A set of transcriptome data of 2752 known metabolic genes was used as a seed for performing non negative matrix factorization (NMF) clustering. Three subtypes of OV (C1, C2 and C3) were found in analysis. The proportion of various immune cells in C1 was higher than that in C2 and C3 subtypes. The expression level of immune checkpoint genes TNFRSF9 in C1 was higher than that of other subtypes. The activation scores of cell cycle, RTK-RAS, Wnt and angiogenesis pathway and ESTIMATE immune scores in C1 group were higher than those in C2 and C3 groups. In the validation set, grade was significantly correlated with OV subtype C1. Functional analysis showed that the extracellular matrix related items in C1 subtype were significantly different from other subtypes. Drug sensitivity analysis showed that C2 subtype was more sensitive to immunotherapy. Survival analysis of differential genes showed that the expression of PXDN and CXCL11 was significantly correlated with survival. The results of tissue microarray immunohistochemistry showed that the expression of PXDN was significantly correlated with tumor size and pathological grade. Based on the genomics of metabolic genes, a new OV typing method was developed, which improved our understanding of the molecular characteristics of human OV.

学科与关键词

关键词
ovarian cancermetabolic genessubtypesmolecular characteristicstumor
相关
加载中…
  • Construction of Metabolic Molecular Classification and Immune Characteristics for the Prognosis Prediction of Ovarian Cancer
    Wang, Kexin; He, Hui; Feng, Xue*Journal of Immunology Research, 2022, 2022: 2359349.被引 2
  • Tumor Immunometabolism Characterization in Ovarian Cancer With Prognostic and Therapeutic Implications
    Yang, Miner; Chen, Gaowen; Gao, Kunjie; Wang, Yifeng*Frontiers in Oncology, 2021, 11: 622752.被引 10
  • A random forest-based metabolic risk model to assess the prognosis and metabolism-related drug targets in ovarian cancer
    Zhang, Haoxin; Chi, Meng; Su, Dongqing; Xiong, Yuqiang; Wei, Haodong; Yu, Yao; Zuo, Yongchun*; Yang, Lei*Computers in Biology and Medicine, 2023, 153: 106432.被引 10
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Oncology
发表日期
2022-05-12
卷期
第 12 卷
页码
877369
DOI
10.3389/fonc.2022.877369
期刊等级
3区
成果收录
SCIE

作者

  • C

    Chen, Zhenyue (第一作者)

    1 · guangzhou univ chinese med

  • J

    Jiang, Weiyi

    1 · shandong univ tradit chinese med

查看全部 5 位作者收起作者
  • L

    Li, Zhen

    2 · guangzhou univ chinese med

  • Z

    Zong, Yun

    1 · guangzhou univ chinese med

  • D

    Deng, Gaopi (通讯)

    1 · guangzhou univ chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417